Certuity’s Boston Scientific BSX Stock Holding History

Certuity’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$237K	Buy	5,559 +309	+6%	+$16.8K	0.01%	574
2026 Q1	$329K	Sell	5,250 -627	-11%	-$50.2K	0.02%	416
2025 Q4	$560K	Buy	5,877 +494	+9%	+$48.4K	0.04%	255
2025 Q3	$525K	Buy	5,383 +1,314	+32%	+$136K	0.04%	255
2025 Q2	$437K	Buy	4,069 +13	+0.3%	+$1.31K	0.04%	226
2025 Q1	$409K	Buy	4,056 +171	+4%	+$17.2K	0.04%	212
2024 Q4	$347K	Buy	3,885 +809	+26%	+$71.2K	0.04%	233
2024 Q3	$258K	Buy	3,076 +75	+2%	+$5.91K	0.03%	294
2024 Q2	$231K	Sell	3,001 -573	-16%	-$41.9K	0.02%	312
2024 Q1	$245K	Buy	3,574 +2	+0.1%	+$129	0.02%	275
2023 Q4	$207K	Buy	+3,572	New	+$191K	0.02%	317

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Certuity's BSX Position: Q2 2026 in Review

Certuity increased its Boston Scientific (BSX) stake by 5.9% in Q2 2026, buying an estimated $16.8K and bringing the position to 5,559 shares worth $237K. The position accounts for 0.01% of the portfolio, ranked #574.

Certuity first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $560K in Q4 2025. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Certuity held 5,559 shares of Boston Scientific worth $237K as of Q2 2026.
Certuity bought 309 Boston Scientific shares in Q2 2026, an estimated $16.8K.
Boston Scientific made up 0.01% of Certuity's portfolio in Q2 2026, its #574 holding.
Certuity first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
Certuity's Boston Scientific position peaked at $560K in Q4 2025.
1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.